An emerging role for nanomaterials in increasing immunogenicity of cancer cell death
- Author
- Tatiana Mishchenko, Elena Mitroshina, Irina Balalaeva, Olga Krysko (UGent) , Maria Vedunova and Dmitri Krysko (UGent)
- Organization
- Abstract
- In the last decade, it has become clear that anti-cancer therapy is more successful when it can also induce an immunogenic form of cancer cell death (ICD). ICD is an umbrella term covering several cell death modalities, including apoptosis and necroptosis. In general, ICD is characterized by the emission of damage-associated molecular patterns (DAMPs) and/or cytokines/chemokines, leading to the induction of strong anti-tumor immune responses. In experimental cancer therapy, new observations indicate that the immunogenicity of dying cancer cells can be improved by the use of biomaterials. In this review, after a brief overview of the basic principles of the concept of ICD and discussion of the potential use of DAMPs as biomarkers of therapy efficacy, we discuss an emerging role of nanomaterials as a promising strategy to modulate the immunogenicity of cancer cell death. We address how nanocarriers can be used to increase the immunogenicity of ICD and then turn our attention to their dual action. Nanocarriers can be used to increase the immunogenicity of dying cancer cells and to reduce the side effects of chemotherapy. Future studies will show whether biomaterials are truly an optimal strategy to modulate the immunogenicity of dying cancer cells and will provide the insights needed for the development of novel treatment strategies for cancer.
- Keywords
- Nanoparticles, Nanocarriers, Biomaterials, Apoptosis, Necroptosis, Immune response, Immunogenicity, Cell death, CALRETICULIN EXPOSURE, IMMUNE-RESPONSES, TGF-BETA, MECHANISMS, EXPRESSION, APOPTOSIS, NECROSIS, THERAPY, TUMORS, IMMUNOTHERAPIES
Downloads
-
(...).pdf
- full text (Published version)
- |
- UGent only
- |
- |
- 1.02 MB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-8612518
- MLA
- Mishchenko, Tatiana, et al. “An Emerging Role for Nanomaterials in Increasing Immunogenicity of Cancer Cell Death.” BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, vol. 1871, no. 1, 2019, pp. 99–108, doi:10.1016/j.bbcan.2018.11.004.
- APA
- Mishchenko, T., Mitroshina, E., Balalaeva, I., Krysko, O., Vedunova, M., & Krysko, D. (2019). An emerging role for nanomaterials in increasing immunogenicity of cancer cell death. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1871(1), 99–108. https://doi.org/10.1016/j.bbcan.2018.11.004
- Chicago author-date
- Mishchenko, Tatiana, Elena Mitroshina, Irina Balalaeva, Olga Krysko, Maria Vedunova, and Dmitri Krysko. 2019. “An Emerging Role for Nanomaterials in Increasing Immunogenicity of Cancer Cell Death.” BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER 1871 (1): 99–108. https://doi.org/10.1016/j.bbcan.2018.11.004.
- Chicago author-date (all authors)
- Mishchenko, Tatiana, Elena Mitroshina, Irina Balalaeva, Olga Krysko, Maria Vedunova, and Dmitri Krysko. 2019. “An Emerging Role for Nanomaterials in Increasing Immunogenicity of Cancer Cell Death.” BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER 1871 (1): 99–108. doi:10.1016/j.bbcan.2018.11.004.
- Vancouver
- 1.Mishchenko T, Mitroshina E, Balalaeva I, Krysko O, Vedunova M, Krysko D. An emerging role for nanomaterials in increasing immunogenicity of cancer cell death. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER. 2019;1871(1):99–108.
- IEEE
- [1]T. Mishchenko, E. Mitroshina, I. Balalaeva, O. Krysko, M. Vedunova, and D. Krysko, “An emerging role for nanomaterials in increasing immunogenicity of cancer cell death,” BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, vol. 1871, no. 1, pp. 99–108, 2019.
@article{8612518,
abstract = {{In the last decade, it has become clear that anti-cancer therapy is more successful when it can also induce an immunogenic form of cancer cell death (ICD). ICD is an umbrella term covering several cell death modalities, including apoptosis and necroptosis. In general, ICD is characterized by the emission of damage-associated molecular patterns (DAMPs) and/or cytokines/chemokines, leading to the induction of strong anti-tumor immune responses. In experimental cancer therapy, new observations indicate that the immunogenicity of dying cancer cells can be improved by the use of biomaterials. In this review, after a brief overview of the basic principles of the concept of ICD and discussion of the potential use of DAMPs as biomarkers of therapy efficacy, we discuss an emerging role of nanomaterials as a promising strategy to modulate the immunogenicity of cancer cell death. We address how nanocarriers can be used to increase the immunogenicity of ICD and then turn our attention to their dual action. Nanocarriers can be used to increase the immunogenicity of dying cancer cells and to reduce the side effects of chemotherapy. Future studies will show whether biomaterials are truly an optimal strategy to modulate the immunogenicity of dying cancer cells and will provide the insights needed for the development of novel treatment strategies for cancer.}},
author = {{Mishchenko, Tatiana and Mitroshina, Elena and Balalaeva, Irina and Krysko, Olga and Vedunova, Maria and Krysko, Dmitri}},
issn = {{0304-419X}},
journal = {{BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER}},
keywords = {{Nanoparticles,Nanocarriers,Biomaterials,Apoptosis,Necroptosis,Immune response,Immunogenicity,Cell death,CALRETICULIN EXPOSURE,IMMUNE-RESPONSES,TGF-BETA,MECHANISMS,EXPRESSION,APOPTOSIS,NECROSIS,THERAPY,TUMORS,IMMUNOTHERAPIES}},
language = {{eng}},
number = {{1}},
pages = {{99--108}},
title = {{An emerging role for nanomaterials in increasing immunogenicity of cancer cell death}},
url = {{http://doi.org/10.1016/j.bbcan.2018.11.004}},
volume = {{1871}},
year = {{2019}},
}
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: